Wolverine Stack Peptides
BPC + TB-500 · BPC-157 + TB-500 blend
The Wolverine stack peptides — BPC-157 and TB-500 (Thymosin Beta-4) — are paired for connective-tissue support during recovery. The BPC-157 and TB-500 blend is widely cited in injury-recovery protocols, though human trial data on either peptide remains limited and the stack's name is informal — it does not appear in the peer-reviewed literature.
The Wolverine Stack stack combines 2 peptides — BPC-157 and TB-500. The reference reconstitution chart below shows each component's typical vial, BAC water, dose, and U-100 syringe units.
Per-component reference presets — when supplied as a single multi-peptide vial, follow your compounder's label. Adjust the calculator below for your vial.
Wolverine Stack dosage calculator
Switch between stack members using the chip strip. Each is preset to a typical vial and dose.
How to use this calculator›
- 1. Vial — the peptide amount printed on the vial, in milligrams.
- 2. BAC water — the bacteriostatic water added to the vial. More water means a lower concentration and a larger, easier-to-read draw.
- 3. Dose — the single dose being measured, in milligrams.
- 4. Syringe — the barrel being drawn into. The diagram rescales to that syringe, so the same dose sits at a different mark on a 0.3 mL barrel than on a U-100.
Educational reference only — not medical advice or a dosing recommendation.
Why these peptides together
BPC-157 and TB-500 act through distinct mechanisms: BPC-157 modulates the nitric-oxide system and growth-factor signalling at the injury site, while TB-500 promotes actin sequestration and cell migration. The two are believed to be complementary rather than competitive, which is the rationale for stacking.
Where researchers source this
Vendors below have been manually vetted for third-party COA practice and shipping reliability. Verify the current Certificate of Analysis on the vendor's product page before purchase.
Ascension PeptidesUSA-based research vendor (Castle Rock, Colorado) publishing a per-batch Certificate of Analysis library with public lot IDs, so a vial can be matched to its own COA before and after purchase. Recent HPLC purity 99.79–99.98% across the catalog. Ships from the US and carries the full GLP-1 reference range alongside repair, longevity and cosmetic compounds.
Visit Ascension Peptides →Affiliate link — we may earn a commission at no extra cost to you.
Particle PeptidesEU-based vendor (Slovakia, since 2015) shipping to EU, UK, and Switzerland. The only European supplier publishing all seven test parameters per batch (purity, identity, content, bioburden, endotoxins, heavy metals class 1 & 2). Manufacturer is cGMP / ISO 9001 / ISO 13485 compliant.
Visit Particle Peptides →Affiliate link — we may earn a commission at no extra cost to you.
How it's typically run
Both peptides are reconstituted separately. Common patterns: BPC-157 250–500 µg one to three times daily near the injury site, alongside a TB-500 loading phase of 2–5 mg twice weekly for 4–6 weeks followed by a 2 mg weekly maintenance dose. Some users alternate injection sites; others co-draw both peptides into a single insulin syringe at the time of administration.
Frequently asked questions
- Why is it called the Wolverine stack?
- An informal nickname referencing the X-Men character's accelerated healing. The label is not used in clinical literature — it originated in injury-recovery and bodybuilding communities.
- Can I mix BPC-157 and TB-500 in the same vial?
- Most protocols keep them in separate vials and either co-draw at the time of injection or alternate injection sites. Separate reconstitution avoids stability questions and lets each peptide's dose be adjusted independently.
- Is the Wolverine stack supported by human trials?
- No. Both BPC-157 and TB-500 have animal data and case reports, but no large-scale randomized human trials of the combination have been published.
PeptideDose is an educational reference. It is not medical advice and does not replace consultation with a licensed healthcare provider. Doses shown in presets are derived from published protocols and product labels — they are not personal recommendations.